2012-05-15 – Page 2 – China Stock Advice

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q:

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer May 15, 2012] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bing Mei Chief Financial Officer May 15, 2012]

By info| 2016-03-01T04:43:50+00:00 May 15th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 10-Q, 2012-05-15, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

CYD [CHINA YUCHAI INTERNATIONAL] 6-K: (Original Filing)

[CHINA YUCHAI INTERNATIONAL LIMITED To all Shareholders Meeting CHINA YUCHAI INTERNATIONAL LIMITED Company NOTICE IS HEREBY GIVEN that the Annual General Meeting (the As Ordinary Business 1. To receive and adopt the audited financial statements and independent auditors report for the financial year ended December 31, 2011. 2. To approve an increase in the limit of the Directors fees] [EX-99.2 3 d352781dex992.htm EX-99.2]

By info| 2016-03-02T22:47:49+00:00 May 15th, 2012|Categories: Chinese Stocks, CYD, SEC Original|Tags: 0000932695, 2012-05-15, 3510, 6-K, CYD, ENGINES and TURBINES|0 Comments

CLNT [Cleantech Solutions International,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x For the quarterly period ended March 31, 2012 o For the transition period from __________ to __________ CLEANTECH SOLUTIONS INTERNATIONAL, DELAWARE 74-2235008 (State or other jurisdiction of (I.R.S. Employerorporation of organization) Identification No.) No. 9 Yanyu Middle Road Qianzhou Township, Huishan District, Wuxi City] [SARBANES-OXLEY ACT OF 2002 I, Jianhua Wu, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Cleantech Solutions International,; 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICERRBANES-OXLEY ACT OF 2002 I, Wanfen Xu, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Cleantech Solutions International,; 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Jianhua Wu ChiefExecutive Officer Wanfen Xu ChiefFinancial Officer (Principal Accounting Officer) CERTIFICATION f10q0312ex32i_cleantech.htm 4 EX-32.1]

By info| 2016-02-02T23:39:48+00:00 May 15th, 2012|Categories: Chinese Stocks, CLNT, SEC Original|Tags: 0000819926, 10-Q, 2012-05-15, 3550, CLNT, SPECIAL INDUSTRY MACHINERY (NO METALWORKING MACHINERY)|0 Comments

CYD [CHINA YUCHAI INTERNATIONAL] 6-K: CHINA YUCHAI INTERNATIONAL LIMITED To all Shareholders Meeting

[CHINA YUCHAI INTERNATIONAL LIMITED To all Shareholders Meeting CHINA YUCHAI INTERNATIONAL LIMITED Company NOTICE IS HEREBY GIVEN that the Annual General Meeting (the As Ordinary Business 1. To receive and adopt the audited financial statements and independent auditors report for the financial year ended December 31, 2011. 2. To approve an increase in the limit of the Directors fees] [EX-99.2 3 d352781dex992.htm EX-99.2]

By info| 2016-03-02T22:49:01+00:00 May 15th, 2012|Categories: Chinese Stocks, CYD, Webplus ver|Tags: 0000932695, 2012-05-15, 3510, 6-K, CYD, ENGINES and TURBINES|0 Comments

HOLI [Hollysys Automation Technologies] 6-K: (Original Filing)

[Hollysys Automation Technologies Reports Unaudited Financial Results for the Fiscal Year 2012 Third Quarter Ended March 31, 2012 Q3 Financial Highlights · Quarterly revenues of $66.1 million, representing an increase of 18.6% compared to $55.8 million year-over-year. · Gross margin at 39.3%, as compared to 40.3% year-over-year, and 38.5% quarter-over-quarter · Non-GAAP net income attributable to Hollysys of $11.6 million,]

By info| 2016-03-10T08:55:39+00:00 May 15th, 2012|Categories: Chinese Stocks, HOLI, SEC Original|Tags: 0001357450, 2012-05-15, 3620, 6-K, ELECTRICAL INDUSTRIAL APPARATUS, HOLI|0 Comments

KNDI [Kandi Technologies] 10-Q: (Original Filing)

[] [SHARE EXCHANGE AGREEMENT By and Among Kandi Technologies, Corp. and KO NGA Investment Limited and GAO SHUPING and ZHENG XIUJIN and HU QIKUN and XU WENGE and LUO XIANSONG and LI QIAOHONG and WANG YINGXIONG Dated as of February 13, 2012 SHARE EXCHANGE AGREEMENT Kandi Technologies, Corp. (“Kandi KO NGA Investment Limited KO NGA Seller Sellers This Share Exchange Agreement] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies, Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zhu Xiaoying, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies, Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. May 15, 2012 May 15, 2012]

By info| 2016-03-18T15:08:06+00:00 May 15th, 2012|Categories: Chinese Stocks, KNDI, SEC Original|Tags: 0001316517, 10-Q, 2012-05-15, 3711, KNDI, MOTOR VEHICLES and PASSENGER CAR BODIES|0 Comments

SORL [SORL Auto Parts] 10-Q:

[] [Certification of Chief Executive Officer of the Sarbanes-Oxley Act of 2002 I, Xiao Ping Zhang, certify that: 1. I have reviewed this Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Certification of Principal Accounting Officer of the Sarbanes-Oxley Act of 2002 I, Zong Yun Zhou, certify that: 1. I have reviewed this Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Dated: May 15, 2012 Xiao Ping Zhang Chief Executive Officer Zong Yun Zhou Chief Financial Officer (Principal Accounting Officer)]

By info| 2016-03-26T21:57:56+00:00 May 15th, 2012|Categories: Chinese Stocks, SORL, Webplus ver|Tags: 0000714284, 10-Q, 2012-05-15, 3714, MOTOR VEHICLE PARTS and ACCESSORIES, SORL|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of March 31, 2012 (unaudited) and December 31, 2011 4ndensednsolidated Statements ofome andmprehensiveome for the Three Months Ended March 31, 2012 and 2011 (unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer May 15, 2012] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Bing Mei Chief Financial Officer May 15, 2012]

By info| 2016-02-05T03:13:40+00:00 May 15th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 10-Q, 2012-05-15, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

HOLI [Hollysys Automation Technologies] 6-K: Hollysys Automation Technologies Reports Unaudited Financial Results for

[Hollysys Automation Technologies Reports Unaudited Financial Results for the Fiscal Year 2012 Third Quarter Ended March 31, 2012 Q3 Financial Highlights · Quarterly revenues of $66.1 million, representing an increase of 18.6% compared to $55.8 million year-over-year. · Gross margin at 39.3%, as compared to 40.3% year-over-year, and 38.5% quarter-over-quarter · Non-GAAP net income attributable to Hollysys of $11.6 million,]

By info| 2016-03-10T08:56:49+00:00 May 15th, 2012|Categories: Chinese Stocks, HOLI, Webplus ver|Tags: 0001357450, 2012-05-15, 3620, 6-K, ELECTRICAL INDUSTRIAL APPARATUS, HOLI|0 Comments

KNDI [Kandi Technologies] 10-Q:

[] [SHARE EXCHANGE AGREEMENT By and Among Kandi Technologies, Corp. and KO NGA Investment Limited and GAO SHUPING and ZHENG XIUJIN and HU QIKUN and XU WENGE and LUO XIANSONG and LI QIAOHONG and WANG YINGXIONG Dated as of February 13, 2012 SHARE EXCHANGE AGREEMENT Kandi Technologies, Corp. (“Kandi KO NGA Investment Limited KO NGA Seller Sellers This Share Exchange Agreement] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies, Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zhu Xiaoying, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies, Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. May 15, 2012 May 15, 2012]

By info| 2016-03-18T15:09:36+00:00 May 15th, 2012|Categories: Chinese Stocks, KNDI, Webplus ver|Tags: 0001316517, 10-Q, 2012-05-15, 3711, KNDI, MOTOR VEHICLES and PASSENGER CAR BODIES|0 Comments